Department of Cardiovascular, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
Eur Rev Med Pharmacol Sci. 2020 Dec;24(24):12859-12866. doi: 10.26355/eurrev_202012_24188.
The purpose of this study was to elucidate the role of long non-coding RNA (lncRNA) UCA1 in inducing the repair of hyperglycemic vascular smooth muscle cells (VSMCs) by targeting microRNA-582-5p (miR-582-5p), thus alleviating diabetic angiopathy.
Arterial vessels and serum exosomes were collected from 40 type 2 diabetes mellitus (T2DM) patients and 40 non-T2DM patients. Relative levels of UCA1 and miR-582-5p in collected samples were detected. Then, the interaction between UCA1 and miR-582-5p was assessed by Dual-Luciferase reporter assay. Moreover, the regulatory effects of UCA1 and miR-582-5p on VSMCs phenotypes were determined.
Results showed that compared with non-T2DM patients, UCA1 was markedly downregulated, while miR-582-5p was upregulated in VSMCs and serum exosomes of T2DM patients. They exerted a negative expression correlation between each other. Besides, miR-582-5p was the direct target of UCA1. Under the induction of increased doses of glucose, UCA1 stimulated proliferative and invasive abilities in VSMCs. MiR-582-5p was responsible for the repairability of UCA1 in VSMCs under the hyperglycemia state.
LncRNA UCA1 induces the repair of hyperglycemic VSMCs via negatively regulating miR-582-5p. UCA1 may be a novel target for T2DM diagnosis and treatment.
本研究旨在阐明长链非编码 RNA(lncRNA)UCA1 通过靶向 microRNA-582-5p(miR-582-5p)诱导高血糖血管平滑肌细胞(VSMCs)修复的作用,从而缓解糖尿病血管病变。
收集 40 例 2 型糖尿病(T2DM)患者和 40 例非 T2DM 患者的动脉血管和血清外泌体。检测收集样本中 UCA1 和 miR-582-5p 的相对水平。然后,通过双荧光素酶报告基因实验评估 UCA1 和 miR-582-5p 之间的相互作用。此外,还确定了 UCA1 和 miR-582-5p 对 VSMCs 表型的调节作用。
结果表明,与非 T2DM 患者相比,T2DM 患者的 VSMCs 和血清外泌体中 UCA1 明显下调,而 miR-582-5p 上调。它们之间存在负表达相关性。此外,miR-582-5p 是 UCA1 的直接靶标。在高浓度葡萄糖的诱导下,UCA1 刺激 VSMCs 的增殖和侵袭能力。miR-582-5p 负责 UCA1 在高糖状态下对 VSMCs 的修复。
lncRNA UCA1 通过负调控 miR-582-5p 诱导高血糖 VSMCs 的修复。UCA1 可能是 T2DM 诊断和治疗的新靶点。